Skip to content
BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

Glucose Health, Inc. GLUC

7 fiscal years on record · USD · FY2016 reported · SEC filings only
$313,229
▲ 7232.1% YoY
$-410,443

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 313,229.00
Revenue, FY2016 · full 7-year series below
Revenue $M Net income $M
FY2016 · Revenue 0.3 · Net income -0.4
0.1M0.3M-1.0M-2.0M
201020132016
Compound annual growth
+1018.2%
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2015 · Operating -3655.7%
-200000%-400000%
201020132016
ROE

Not applicable: equity was zero or negative in this period, so return on equity has no meaning.

Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.

Cash & shareholders

·
returned in FY2016 · dividends + net buybacks

Total assetsUSD 33,145.00
EquityUSD -495,447.00
CashUSD 20,542.00
Current ratio0.06×

Equity funds -1495% of total assets.

The 7-year record

7 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
GLUC, 7-year financial record
Metric 2016201520142013201220112010
Revenue $B0.00.00.00.0◌◌0.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B◌◌◌◌◌◌◌
Income tax $B◌◌◌◌◌◌◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−0.15−0.14−0.99−4.91−0.05−0.02−0.03
Dividend / sh $◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————
ROE % — not applicable: negative equity———————
Shares out B0.000.000.000.020.100.070.02

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 33 reconciliationsAUDITED

Reconciled in 7 of the 7 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Three checks were skipped: EPS is not tagged before 2010. Three checks were skipped: revenue is not tagged before 2010.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image